Sponsor or institution

Clinical trials and research at Universität Münster

• 13Clinical trials
• 4Countries

Newest trials

All recruiting trials (13)

• Sodium bicarbonate for critically ill patients with metabolic acidosis and AKI

  This trial tests whether giving sodium bicarbonate helps reduce major kidney problems 90 days later in adults with septic or critical illness and kidney injury.

  Recruiting Phase 4 Universität Münster · Münster · NCT07464431

• Combining loncastuximab tesirine and epcoritamab in relapsed/refractory aggressive B‑cell lymphoma

  In this phase 2 study, researchers will test whether the drug combo loncastuximab tesirine plus epcoritamab can help people with relapsed or refractory aggressive B‑cell lymphomas, including DLBCL, HGBL, or FL 3B, who have failed prior therapies or CAR‑T treatment.

  Recruiting at 30 sites Phase 2 Universität Münster · Aachen and 33 other locations · NCT07197307

• Survey on medication information leaflets for organ transplant patients

  This study is trying to find out what organ transplant patients and their caregivers think about the medication information leaflets to make them clearer and more helpful.

  Recruiting Universität Münster · Münster, North Rhine-Westphalia · NCT06652919

• Angiotensin II to reduce kidney injury after heart surgery

  This trial tests whether angiotensin II, used as the primary blood-pressure medicine instead of norepinephrine after cardiac surgery with cardiopulmonary bypass, can lower the chance of moderate or severe acute kidney injury in adults at higher risk.

  Recruiting at 4 sites Phase 3 Universität Münster · Berlin and 3 other locations · NCT06615102

• FAPI-PET/MRI to detect hidden invasive cancer in DCIS

  This imaging study tests whether FAPI-PET/MRI can reveal invasive breast cancer that isn’t obvious in DCIS patients.

  Recruiting Phase 2 Universität Münster · Essen, North Rhine-Westphalia and 1 other locations · NCT06540872

• Investigating nephroprotective measures for critically ill patients with acute kidney injury

  This study looks at how well hospitals follow guidelines to protect the kidneys of critically ill patients with moderate to severe acute kidney injury to see if it can help improve their care.

  Recruiting at 3 sites Universität Münster · Innsbruck and 2 other locations · NCT06472999

• Evaluating cardiac output measurement methods in critically ill patients on life support

  This study is testing if a method that measures energy use can accurately estimate heart function in critically ill patients on life support.

  Recruiting Universität Münster · Münster · NCT06369818

• Comparing standard and low-dose continuous renal replacement therapy for acute kidney injury

  This study tests whether using a standard dose or a lower dose of a kidney treatment can help critically ill patients with acute kidney injury recover better.

  Recruiting at 2 sites Universität Münster · Münster and 1 other locations · NCT06021288

• Using clindamycin to improve treatment of skin infections caused by Staphylococcus aureus

  This study is testing if adding clindamycin to regular treatment can help adults in Sierra Leone recover faster from skin infections caused by Staphylococcus aureus.

  Recruiting Phase 4 Universität Münster · Masokori · NCT05899140

• Investigating hormone differences in cardiac surgery patients

  This study looks at hormone levels in patients having different types of heart surgery to see how these levels might affect complications like low blood pressure during the procedure.

  Recruiting at 2 sites Universität Münster · Berlin and 1 other locations · NCT05833828

• Using remote ischemic preconditioning to prevent kidney injury in septic patients

  This study is testing if a special technique that temporarily restricts blood flow in the arm can help prevent kidney injury in critically ill patients with sepsis.

  Recruiting Universität Münster · Münster · NCT05830669

• Combination treatment for advanced soft tissue sarcoma

  This study is testing if adding a new treatment called tTF-NGR to standard chemotherapy can help people with advanced soft tissue sarcoma live longer without their cancer getting worse.

  Recruiting at 9 sites Phase 3 Universität Münster · Bad Saarow and 8 other locations · NCT05597917

• Using Gliolan with Radiotherapy for Recurrent Brain Tumors

  This study is testing if a new drug called Gliolan can make radiotherapy more effective for patients with recurrent brain tumors after surgery.

  Recruiting Phase 1/2 Universität Münster · Münster · NCT05590689

Quick answers

How many clinical trials run by Universität Münster are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in Germany (12 trials), Austria (1 trial), Netherlands (1 trial), Sierra Leone (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 2, Phase 4: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →